verified SJR 1,834 · Q1 • database Scopus / SJR & Web of Science indexed

United States · Elsevier Inc.

workspace_premium Q1 — Cardiology and Cardiovascular Medicine lock Subscription

Chest

Chest is a journal indexed in SJR in Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine with an H index of 337. It has a price of 2970 €. It has an SJR impact factor of 1,834 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,834.

Chest focuses its scope in these topics and keywords: lung, patients, pulmonary, treatment, critically, yearold, care, airway, chest, chronic, ...

ISSN: 0012-3692

Publisher: Elsevier Inc.

Category: Cardiology and Cardiovascular Medicine

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,834 Q1

H-index 337

Acceptance rate pie_chart

17% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.970 € Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,834

H-index

337

Docs (year)

565

Docs 3y

2194

Total refs

12503

Cites 3y

7444

Citable 3y

1336

Cites/Doc 2y

3.34

Ref/Doc

22.13

Immediate OA

2970 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Clinical Characteristics of Tuberculosis Patients Who Were on Therapy of Tumor Necrozing Factor Alpha Antagonists

Validation of the European Respiratory Society Guidelines for Pseudomonas aeruginosa Risk Factors in Patients With COPD Exacerbations

Efficacy of Lymph Node Dissection During Robotic-Assisted Pulmonary Lobectomy for Non-small Cell Lung Cancer: Retrospective Analysis of 159 Consecutive Cases

Efficacy of Levodropropizine: 2 Meta-analyses in Pediatric and Adult Population

Effects of Pulmonary Function and of Smoking History on Perioperative Outcomes After Robotic-Assisted Pulmonary Lobectomy: Retrospective Analysis of 201 Consecutive Patients

Disseminated Neosartorya pseudofischeri Infection Associated With Tracheal Bronchus Post Lung Transplantation

Detection of Opioid Induced Respiratory Depression and Postoperative Apnea Using a Noninvasive Respiratory Volume Monitor

Delayed Presentation of Breast Cancer Metastatic to Solitary Fibrous Tumor of the Lung With Synchronous Contralateral Primary Non-small Cell Lung Cancer: A Case Report

Delayed Diagnosis of Sarcoidosis in Patient With Asthma-like Symptoms

Confocal Laser Endomicroscopy to Improve Diagnostic Yield of Pulmonary Nodule and Mass

Concurrent Robotic-Assisted Pulmonary Lobectomy and Robotic-Assisted Ivor-Lewis Esophagectomy for Synchronous Primary Lung and Esophageal Cancers: A Case Report

Computed Tomography of the Chest: Indications and Utilization in the Community Hospital Emergency Department

SHOW MORE ARTICLES

Clinical Efficacy of Azithromycin in Patients With Severe Sepsis: Open Label Pilot Randomized Controlled Trial

A 65 Year Old Man With Multiple Pulmonary Amyloidomas

Causes of Prolonged Mechanical Ventilation After Coronary Artery Bypass Surgery

Can Manometry Prevent Chest Discomfort During Thoracentesis? A Symptom-based Study

BNP Can Be an All-Cause Mortality Predictor in Sarcoidosis

Are Pseudomonas aeruginosa Risk Factors Associated With Pseudomonas Acute Exacerbation of COPD?

Analysis in the Promoter Region of TRPC6 Gene in Patients With Pulmonary Arterial Hypertension

An Early Phenotype Allows Distinction of Survivors From Nonsurvivors in Sepsis

Alpha-1 Antitrypsin Levels and Genotypes in Children With Primary Spontaneous Pneumothorax

Adherence to Continuous Positive Airway Pressure (CPAP) Therapy

Acute Myocardial Depression With Inverted (Reverse) Takotsubo Physiology Following Bupivacaine/Lidocaine Injection for Axillary Nerve Block

A Woman With Lymphangioleiomyomatosis and Acute Pancreatitis

FAQs

Chest has an SJR of 1,834 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 2970 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Chest is 17%.

Chest

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Chest?

What is the APC / publication cost?

What is the acceptance rate?